Spectrawave: Funding, Investors & Team (Sep 2026)
Spectrawave is a company that specializes in creating optical devices for medical purposes, focusing on improving the diagnosis and treatment of cardiovascular diseases. The company operates primarily in the field of diagnostic equipment within the medical industry. It was established in 2017 and is headquartered in Waltham, Massachusetts.
Spectrawave has raised $63.2M across 2 funding rounds on record, the most recent a Series B of $50.0M announced in Sep 2024.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Spectrawave Company Profile and Key Stats
Latest funding round on record: Sep 2024.
Spectrawave Funding Rounds
Spectrawave raised $13.2M in a Series A announced in Feb 2021.
3.6 years later, a Series B of $50.0M was announced in Sep 2024.
Spectrawave Founders and Leadership Team
No contact details are on record for this team yet.
Spectrawave Funding Compared to Other Biotechnology Startups
Spectrawave's latest round of $50.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Spectrawave in Biotechnology and Waltham
Companies Similar to Spectrawave
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Spectrawave Funding FAQs
What does Spectrawave do?
Spectrawave is a company that specializes in creating optical devices for medical purposes, focusing on improving the diagnosis and treatment of cardiovascular diseases. The company operates primarily in the field of diagnostic equipment within the medical industry. It was established in 2017 and is headquartered in Waltham, Massachusetts.
How much funding has Spectrawave raised?
Spectrawave has raised $63.2M across 2 rounds on record. The most recent is a Series B of $50.0M announced in Sep 2024.
When did Spectrawave last raise funding?
Spectrawave's most recent funding round on record is a Series B of $50.0M, announced in Sep 2024.
Who founded Spectrawave?
FundedIQ lists Gregg Stone (Founder) at Spectrawave.
Who is the CEO of Spectrawave?
Eman Namati is listed as CEO at Spectrawave.
Where is Spectrawave headquartered?
Spectrawave is based in Waltham, Massachusetts, United States.
How many employees does Spectrawave have?
Spectrawave is in the 51-100 employee band.
How does Spectrawave's funding compare to other Biotechnology startups?
Spectrawave's latest round of $50.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Spectrawave Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Spectrawave is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.